×
For best experience we recommend to activate Javascript in your browser.
IGFBP7 antibody (AA 88-281)
This Rabbit Polyclonal antibody specifically detects IGFBP7 in WB, IHC, IP and ICC. It exhibits reactivity toward Mouse.
Quick Overview for IGFBP7 antibody (AA 88-281) (ABIN7619920)
Target
See all IGFBP7 Antibodies
IGFBP7
(Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
Reactivity
All reactivities for IGFBP7 antibodies
Mouse
Host
All hosts for IGFBP7 antibodies
Rabbit
Clonality
All clonalities for IGFBP7 antibodies
Polyclonal
Conjugate
All conjugates for IGFBP7 antibodies
This IGFBP7 antibody is un-conjugated
Application
All applications for IGFBP7 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-IGFBP7 Antibody
(hide)
Binding Specificity
All epitopes for IGFBP7 antibodies
AA 88-281
Purpose
Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Polyclonal Antibody
Sequence
Lys88~Leu281
Characteristics
The Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for IGFBP7
(hide)
Target
IGFBP7
(Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
Alternative Name
IGFBP7
Gene ID
29817
UniProt
Q61581
Pathways
Growth Factor Binding
Recently viewed
(hide)
Chat with us , powered by LiveChat